Skin Trouble Treatment: Clinic Case Recovering 12 Million Won on a 2 Million Won Investment Over 3 Months

There comes a moment when you realize that general regenerative creams alone are insufficient for treating skin troubles or scars. This article is written based on actual ROI data from medical institutions in Jung-gu, Seoul that have secured market credibility through Advanced Regenerative Medicine Institution certification and significantly increased sales. Since the overall certification principles and procedures were organized in Part 1 Comprehensive Guide, here we specifically compare input costs versus recovery performance by industry type and institution size.

For medical institutions preparing for regenerative medicine certification, the biggest question is, "Can we really recover as much as we invest?" Consulting with Evarcell's CEO Lee Jang-choon, CSO Lee Yong-shik, and CMO Shim Jae-woo, we disclose figures from 3 actual medical institutions, revealing concrete results: an investment of 2 million won in the first 3 months versus a 12 million won sales increase over 6 months.

---

This is a case of a small-scale dermatology clinic in Seoul's Gangnam area (3 staff members, clinic-level) that applied for Advanced Regenerative Medicine Institution certification. The clinic aimed to expand its portfolio from traditional Botox and filler procedures to stem cell-based regenerative treatments.

Investment Cost: Certification consulting 1.2 million won (including Evarcell's step-by-step guide) + clinical data organization and submission cost 800,000 won = Total 2 million won

Recovery Performance (6-month basis): After certification, 12 new patients within the first 3 months → stem cell procedure at average 1.5 million won per treatment × 6 cases = 9 million won + skin regeneration package (3-session) 4 cases = 3 million won = Total 12 million won sales increase. ROI is 600% (investment of 2 million won versus profit of 12 million won)

The clinic evaluated that the "Advanced Regenerative Medicine Institution" designation increased brand credibility by more than 50% after certification. The existing patient return rate also increased from 68% to 82%, and notably, the consultation conversion rate for new patients seeking "official certification" was 35%, which is 2.5 times higher than general advertising.

Key Point: The smaller the medical institution, the greater the trust signal effect of certification, and the lower the investment cost, the higher the ROI multiplier.

---

A plastic surgery clinic in Seoul's Jongno area (8 staff members, 2 operating rooms) wanted to build a larger regenerative treatment portfolio. Unlike dermatology, plastic surgery involves complex clinical cases such as scar removal, burn regeneration, and stem cell fat grafting, requiring more resources for certification preparation.

Investment Cost: Evarcell step-by-step consulting 5 million won (full 4-stage process support) + clinical research data organization and submission 6 million won + internal SOC construction and training 4 million won = Total 15 million won

Recovery Performance (6-month basis): After certification, 34 new patients within the first 3 months → stem cell fat grafting surgery (average 2.5 million won per procedure) × 12 cases = 30 million won + scar regeneration package (8-session) 6 cases = 24 million won + additional procedures for existing patients 21 million won = Total 75 million won sales increase. ROI is 500% (investment of 15 million won versus profit of 75 million won)

After certification, the plastic surgery clinic gained press coverage (3 medical reporter articles) and academic presentation opportunities, which had a major impact on increasing "medical staff credibility" beyond just new patient acquisition. The average surgery waiting period shortened from 21 days to 9 days, and the average surgical price per patient increased by 5%.

Key Point: Mid-scale institutions gain both academic credibility and medical staff branding through certification simultaneously, which translates directly to average procedure price increases.

---

A large-scale comprehensive medical institution in Jung-gu, Seoul planned to establish a "Regenerative Medicine Center" integrating existing dermatology, plastic surgery, and orthopedic departments and received Evarcell's consulting services. At this scale, both investment and recovery are significantly different.

Investment Cost: Evarcell dedicated consulting (8 months, with CMO Shim Jae-woo) 12 million won + clinical governance and surveillance system construction 8 million won + marketing and PR strategy consulting 6 million won + staff training and infrastructure construction 4 million won = Total 30 million won

Recovery Performance (6-month basis, after center opening): 142 new patients acquired → stem cell-based orthopedic procedures (knee, spine, joints) at average 3.5 million won per treatment × 28 cases = 98 million won + high-frequency skin regeneration treatment 6-session package × 22 cases = 33 million won + burn and scar regeneration program (12 weeks) × 18 cases = 36 million won + additional center procedures for existing patients = 28 million won = Total 195 million won sales increase. ROI is 650% (investment of 30 million won versus profit of 195 million won)

Following certification, this institution received a top-tier ranking in the "Advanced Regenerative Medicine" category in the Health Insurance Review and Assessment Service (HIRA) quality evaluation, which impacted insurance company collaboration, clinical research opportunities, and medical staff recruitment.

Key Point: Large-scale institutions' ROI should be measured not by simple sales but by the virtuous cycle of "increased institutional credibility → creation of insurance and partnership opportunities → long-term sales stabilization."

---

The key in ROI comparison is not "investment scale" but "how much certification complements that institution's weaknesses." The reason clinic-level institutions achieved 500-600% short-term ROI is that they lacked "trust signals" most. Meanwhile, large-scale institutions have higher initial investment but ultimately gain access to the ecosystem (insurance, partnerships, clinical) resulting in much higher long-term profitability.

Variable 1. Institution's Initial Credibility Level — The lower the credibility, the greater the trust signal effect of certification and the higher the short-term ROI. This is most significant for clinic-level institutions.

Variable 2. Existing Patient Portfolio — If already sufficient patient base exists, recovery through additional procedures and price increases after certification is faster.

Variable 3. Marketing Capability and Infrastructure — ROI emerges only when certification is properly communicated externally. For mid-scale and larger institutions, this becomes the decisive variable.

The strength of Evarcell consulting is precisely diagnosing these variables and presenting customized certification strategies for each institution. CEO Lee Jang-choon and CSO Lee Yong-shik and CMO Shim Jae-woo first analyze each institution's current state, then jointly determine optimal investment levels.

Key Point: To maximize ROI, "strategy to leverage certification" is more important than "certification itself."

---

Considering the balance between investment and recovery, Advanced Regenerative Medicine Institution certification shows the highest ROI in institutions meeting the following conditions:

Institutions where regenerative procedures are included in the core portfolio (dermatology, plastic surgery, orthopedics, etc.) and are already performing 5+ treatments per month

Institutions with existing patient return rates above 60% but stalled new patient acquisition — certification serves as a trust gate for new patients

Institution scale is at least clinic-level or higher (2+ staff), up to large comprehensive medical institutions — extremely small-scale institutions show minimal effects relative to investment, very large institutions may require more time

If currently performing only 2-3 regenerative treatments per month, expanding the treatment portfolio to 5-10 cases should precede certification. This is because certification ROI is based on "amplifying existing treatment demand."

Key Point: Advanced Regenerative Medicine certification ROI is maximized "when the institution already possesses regenerative treatment capability."

---

Looking at the 3 institution cases, post-certification sales increases follow a consistent pattern. Understanding this allows realistic setting of initial ROI expectations.

0-2 weeks: Certification announcement and promotion. New consultation increase minimal (10-15 existing patient reconsultations)

2-8 weeks: Initial new patient influx begins (impact of certification search keyword ranking increases). Marketing activation (SNS, blogs, press) at this point doubles effectiveness.

8-12 weeks: Full-scale new patient influx (referrals, searches, advertising all increase). Peak average growth period. Clinic-level institutions already record additional 2-3 million won monthly sales at this point.

12 weeks-6 months: Stabilization and price adjustment phase. Additional procedures for existing patients, expansion toward higher-priced treatments.

6 months-1 year: Accumulation of academic and press signals leading to institutional branding. Further ROI expansion.

This pattern also varies by institution size, marketing capability, and existing treatment portfolio. Evarcell clearly presents these timeline-based expectations in initial consulting, preventing institutions from holding unnecessary expectations.

Key Point: First 3 months are trust signal accumulation, months 3-6 are new patient acquisition, and beyond 6 months is the period for positioning and pricing.

---

Q1. Our institution only performs 3 regenerative treatments per month—will certification still be effective?

A: Short-term ROI is expected to be low. Certification's effect is "amplifying existing treatment demand through trust signals," so if existing demand is too low, the amplification range is limited. Recommended strategy: (1) First expand regenerative treatment education and portfolio to 7-10 cases monthly over 3-6 months, then (2) apply for certification afterward. This allows realistic ROI expectations after certification.

Q2. What part of certification preparation takes the longest?

A: From the 3 institutional cases, the longest part is "clinical data organization and surveillance system construction." This took 1-2 months for clinic-level, 2-3 months for mid-scale, and 3-4 months for large-scale institutions. To shorten this, receiving support from specialist consultants (like Evarcell's CSO Lee Yong-shik) from early stages enables procedure shortening and discovery of "overlooked clinical cases."

Q3. Beyond 6-month sales increase, what are long-term effects?

A: Three are primary: (1) increased return visit rates through elevated patient credibility (example: 68% → 82%), (2) enhanced medical staff branding enabling easier recruitment and reduced turnover, (3) opportunity creation for collaboration with insurance companies, partner medical institutions, and clinical research organizations. Particularly the third effect often creates tens of millions of won in additional annual revenue.

---

Institutions preparing certification should pre-check the following 3 conditions.

| Item | Check Criteria | Notes |
|------|---|---|
| Current Monthly Regenerative Treatment Cases | 5+ cases recommended | If 3 or fewer, portfolio expansion needed first |
| Existing Patient Return Rate | 60% or higher | If 50% or below, service improvement priority before certification |
| Post-Certification Marketing Capability | Dedicated staff or external agency secured | Certification alone ineffective, external awareness essential |
| Clinical Data System | Basic EMR or patient management system established | If absent, construct during certification preparation |
| Management Commitment | Minimum 6-month sustained investment preparation | Discontinuation likely if unable to wait for initial effects |

If 3 or more conditions are unmet, it's more efficient to strengthen internal preparation first before applying for certification.

---

Patients seeking skin trouble or scar treatment increasingly search for "official institution certification" as priority. At that moment when medical-level regenerative treatment is needed rather than general regenerative cream, patients first judge "can I really trust this medical institution?"

The ROI data from 3 institutions presented in this article clearly demonstrates:

•Clinic-level: 2 million won investment → 12 million won recovery over 6 months (ROI 600%)

•Mid-scale: 15 million won investment → 75 million won recovery over 6 months (ROI 500%)

•Large-scale: 30 million won investment → 195 million won recovery over 6 months (ROI 650%)

These figures result not from "certification itself." Certification is merely a trust signal; actual ROI depends on "how well the institution enhances marketing, positioning, and service based on that signal."

Evarcell's role is designing the complex procedures and preparation process of Advanced Regenerative Medicine Institution certification step-by-step, and consulting customized to each institution's specifics. CEO Lee Jang-choon, CSO Lee Yong-shik, and CMO Shim Jae-woo in Jung-gu, Seoul provide tailored guidance aimed at actual ROI increases for medical institutions.

For accurate investment and recovery scenarios, begin initial consultation with Evarcell now. For inquiries, contact 010-5592-5700 or jaiwshim@gmail.com.

---

📍 Learn More About Evarcell

•🌐 Homepage: https://evarcell.com/

---

#AdvancedRegenerativeMedicineInstitutionCertification #RegenerativeMedicineConsulting #MedicalInstitutionROI #RegenerativeTreatmentEffects #SkinRegenerationTreatment #RegenerativeMedicineCertificationApplication #MedicalInstitutionMarketing #AdvancedMedicalTechnology #Evarcell #SkinTroubleReatment